Global Immuno-oncology Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Scope of the Report:

This report focuses on the Immuno-oncology Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Immuno-oncology Drugs is expected to grow at a CAGR of roughly 14.2% over the next five years, will reach 109200 million US$ in 2023, from 49200 million US$ in 2017, according to a new study.



Market Segment by Manufacturers, this report covers

Amgen, Inc

AstraZeneca, Plc

Bristol-Myers Squibb

Celgene Corporation

Eli Lilly and Company

Merck & Co.

Hoffmann-La Roche AG

Johnson & Johnson

Novartis International AG

AbbVie, Inc.

Pfizer Inc.

Sanofi S.A.

EMD Serono, Inc.

Gilead Sciences Inc.

Prometheus Therapeutics & Diagnostics

Aduro BioTech

Galena Biopharma

Bavarian Nordic

Celldex Therapeutics

ImmunoCellular Therapeutics

Incyte



Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)



Market Segment by Type, covers

Immune Checkpoint Inhibitors

Monoclonal Antibodies

Cytokine-Based Immunotherapy

Cancer Vaccines

CAR-T Cell Therapy



Market Segment by Applications, can be divided into

Hospitals

Pharmacies

Online Pharmacies



There are 15 Chapters to deeply display the global Immuno-oncology Drugs market.

Chapter 1, to describe Immuno-oncology Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Immuno-oncology Drugs, with sales, revenue, and price of Immuno-oncology Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Immuno-oncology Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Immuno-oncology Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Immuno-oncology Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions